Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities

Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases

OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants

New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences

Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery

The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners

Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations

CSIR-HRDC hosts intensive workshop on AI-driven drug discovery for scientists

Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise

Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health

TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners

Viva Biotech supercharges AI-driven drug discovery with NVIDIA tech

The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology

Merck, Mayo Clinic forge AI powerhouse to accelerate drug discovery

Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery

The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research